Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial.
Arrigo Francesco Giuseppe CiceroAmirhossein SahebkarFederica FogacciMarilisa BoveMarina GiovanniniClaudio BorghiPublished in: European journal of nutrition (2019)
In conclusion, the present trial shows that supplementation with a phytosomal preparation of curcumin containing phosphatidylserine and piperine could improve glycemic factors, hepatic function and serum cortisol levels in subjects with overweight and impaired fasting glucose.
Keyphrases
- insulin resistance
- clinical trial
- phase ii
- phase iii
- placebo controlled
- double blind
- study protocol
- blood glucose
- type diabetes
- open label
- glycemic control
- adipose tissue
- high fat diet
- metabolic syndrome
- skeletal muscle
- physical activity
- weight loss
- randomized controlled trial
- polycystic ovary syndrome
- body composition
- high fat diet induced
- phase ii study
- molecularly imprinted
- high resolution
- liver fibrosis